Neuro: GBS Flashcards
Typical presentation of GBS?
Ascending motor and sensory disturbance following recent gastric symptoms
Most common cause of peripheral neuropathy in western world?
Guillain-Barre Syndrome
Guillan-Barré syndrome is an “acute paralytic polyneuropathy” that affects the peripheral nervous system. It causes acute, symmetrical, ascending weakness and can also cause sensory symptoms. It is usually triggered by an infection and is particularly associated with to campylobacter jejuni, cytomegalovirus and Epstein-Barr virus.
Subtypes of GBS?
95% - acut inflammatory demyelinating polyradiculopathy -AIDP (sensory motor neuropathy +/- autonomic features
AMAN - acute axonal neuropathy - much worse prognosis -
AMSAN - acute motor and sensory axonal neuropathy
Acute pandysautonomia
Overlap- Miller Fisher syndrome (sensory ataxia, arreflexia, opthalmoplegia)
PATHOPHYSIOLOGY OF GBS
Guillain-Barré is thought to occur due to a process called molecular mimicry.
The B cells of the immune system create antibodies against the antigens on the pathogen that causes the preceding infection.
These antibodies also match proteins on the nerve cells. (Cross reaction with schwann cell/ (axolemma) antigens
They may target proteins on the myelin sheath of the motor nerve cell or the nerve axon.
This impairs neurotransmission to the periphary
May be damage to sensory and motor nerves in the somatic division of the PNS, but also the autonomic division (causing symptoms such as labile heart rate and blood pressure)
Occurs 1-3 weeks after immunesystem stimulation (or other inflammatory event - trauma, surgery, vaccination, pregnancy)
Triggers of GBS?
campylobacter jejuni,
cytomegalovirus
Epstein-Barr virus
GBS symptoms?
Symmetrical ascending weakness (starting at the feet and moving up the body)
Reduced reflexes
There may be peripheral loss of sensation or neuropathic pain
It may progress to the cranial nerves and cause facial nerve weakness
How long after inflammatory event (usually infection such as GI or URTI) does GBS begin?
1-3 weeks after immune system stimulation
Clinical course of Guillain-Barre syndrome?
The symptoms typically start in the feet and progresses upward. (rapidly ascending weakness over hours to days)
FEVER IS ABSENT AT ONSET
Relatively synettric with mild sensory signs or symptom
Lower motor neuron signs develop
Symptoms peak within 2-4 weeks, then there is a recovery period that can last months to years.
Usually monophasic, self limiting
If surpasses 8 weeks without improvement or plataue prognosis is poorer
What is CIDP (chronic inflammatory demyelinating polyradiculoneuropathy)
GBS symptoms which reach 8 weeks without plateau or improvement
Relapsing course requiring repeated treatment over long periods of time
Radiculoneuropathy - condition starts in nerve roots - pts often complain of midback pain preceeding weakness and sensory symptoms occur
How is GBS diagnosed?
A diagnosis of Guillain-Barré syndrome is made clinically. The Brighton criteria can be used for diagnosis.
Diagnosis can be supported by investigations:
Nerve conduction studies (reduced signal through the nerves)
Lumbar puncture for CSF (raised protein with a normal cell count and glucose)
Nerve conduction studies in GBS?
Reduced signals through nerves
May only show very subtle abnormalities in the first week: prolonged F waves - indicating nerve root involvement
CSF in GBS?
May be normal in first 1-2 weeks (should still be done early, r/o other differentials)
Increase protein
Normal or mildly raised lymphocytes
How might you investigate GBS?
Lumbar puncture
Nerve conduction studies
Consider serology: camplyobacter if GI upset, CMV, EBV, HSV, HIV, mycoplasma
Stool coltures
Throat swab
(Not first line, if suspecting known GBS syndromes of MF syndrome)
Anti-ganglioside antibodies - AMAN - anti GM1, C Jejuni, MF - antiGQ1B
What autonomic symptoms may occur in GBS?
Labile pulse and blood pressure
Urinary retention
Illeus
Complications of GBS?
Autonomic dysfunction
Type II respiratory failure
Although prognosis usually good, 25% may need ventilatory support - monitor FVC in these patients to consider ITU involvement
DVT/PE - immobile or reduced mobility
Pain
SIADH
Renal failure secondary to IVIG treatment
Hypercalcemia (long term immobility)